Breadcrumb
NIH Guide: Weekly Index for March 13, 2020
Weekly NIH Funding Opportunities and Notices
March 13, 2020
Policy Notices
-
Reminder: FORMS-F Grant Application Forms & Instructions Must be Used for Due Dates On or After May 25, 2020- New Grant Application Instructions Now Available
(NOT-OD-20-077)National Institutes of HealthAgency for Healthcare Research and Quality
-
NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
(NOT-OD-20-082)National Institutes of Health
-
General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
(NOT-OD-20-083)National Institutes of Health
-
Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
(NOT-OD-20-086)National Institutes of Health
General Notices
-
Clarification of Research Strategy Structure for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed."
(NOT-FD-20-011)Food and Drug Administration
-
Notice of Change to the Application Due Date for RFA-FD-20-012 titled "Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Clinical Trials Not Allowed"
(NOT-FD-20-016)Food and Drug Administration
-
The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2020 SGM Research Investigator Awards Program
(NOT-OD-20-078)National Institutes of Health
-
Request for Information (RFI): Biological Research Needs for High Spatial Resolution Imaging Supported by the Department of Energy and the National Institutes of Health
(NOT-GM-20-021)National Institute of General Medical SciencesNational Institute of Biomedical Imaging and Bioengineering
-
Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics
(NOT-RM-20-014)Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
-
Notice of NIEHS Participation in PAR-20-125 "Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)"
(NOT-ES-20-013)National Institute of Environmental Health Sciences
-
Notice of Change to the Application Due Date and Award Budget for RFA-FD-20-020 titled Renewal - Investigation of impact of manufacturing difference and formulation variation on drug release for Levonorgestrel Intrauterine System (U01)
(NOT-FD-20-010)Food and Drug Administration
-
Notice of change to R&R Budget for RFA-FD-20-026 Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (U01) Clinical Trials Not Allowed
(NOT-FD-20-012)Food and Drug Administration
-
Notice of Change to the Application Due Date for RFA-FD-20-007 titled "Center for Collaborative Research on Complex Generics (U18) Clinical Trials Optional."
(NOT-FD-20-013)Food and Drug Administration
-
Notice of Change to the Application Due Date for PAR-19-190 titled "Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional."
(NOT-FD-20-014)Food and Drug Administration
-
Notice of Change to the Application Due Date for PAR-19-216 titled "Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional."
(NOT-FD-20-015)Food and Drug Administration
-
Notice to extend the 2020 Application Due Date for PAR-20-091 "Revision Applications - FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed)"
(NOT-FD-20-017)Food and Drug Administration
-
Notice of NHGRI Participation in PAR-20-039, Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)
(NOT-HG-20-025)National Human Genome Research Institute
-
Notice of NHGRI Participation in PAR-20-040, Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed)
(NOT-HG-20-026)National Human Genome Research Institute
-
Notice of NHGRI Participation in PAR-20-041, Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed)
(NOT-HG-20-027)National Human Genome Research Institute
-
Notice of Change in Key Dates for RFA-MH-20-400 "Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 CT Optional)"
(NOT-MH-20-042)National Institute of Mental Health
-
Notice of Change in Key Dates for RFA-MH-20-401 "Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required)"
(NOT-MH-20-043)National Institute of Mental Health
-
Notice of Change to salary allowance for K00 awardees for NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
(NOT-NS-20-040)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Change to Key Dates for PA-18-358 "NINDS Exploratory Neuroscience Research Grant (R21 - Clinical Trial Optional)"
(NOT-NS-20-042)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest: Digital Technology for Early Detection of Alzheimers Disease and Related Dementias
(NOT-AG-20-017)National Institute on Aging
-
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)
(NOT-CA-20-031)National Cancer InstituteNational Institute of Dental and Craniofacial Research
-
Notice of Special Interest: Administrative Supplements to Support Resource Hubs to Promote Multi-Sectoral Rural Health Disparities Research
(NOT-MD-20-010)National Institute on Minority Health and Health Disparities
-
Notice of Special Interest for HEAL Initiative: Request for Administrative Supplements to Existing Grants for Identification and Validation of New Pain and Opioid Use Disorder Targets within the Understudied Druggable Genome
(NOT-TR-20-008)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative Health
Funding Opportunities
-
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
(PA-20-135)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthOffice of Strategic Coordination (Common Fund)National Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesApplication Receipt Date(s): See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
(PAR-20-131)National Cancer InstituteApplication Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 05, 2020
-
Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18) Clinical Trial Not Allowed
(PAR-20-132)Food and Drug AdministrationApplication Receipt Date(s): May 13, 2020 by 11:59 PM Eastern Time. February 15, 2021 by 11:59 PM Eastern Time. February 15, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)
(PAR-20-133)National Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer InstituteApplication Receipt Date(s): June 18, 2020; June 8, 2021
-
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)
(PAR-20-134)National Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer InstituteApplication Receipt Date(s): June 18, 2020; June 08, 2021
-
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
(PAR-20-136)National Cancer InstituteApplication Receipt Date(s): April 7, 2020; November 9, 2020; April 9, 2021; November 9, 2021; April 7, 2022; November 9, 2022
-
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
(PAR-20-137)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Dental and Craniofacial ResearchOffice of Research on Women's HealthApplication Receipt Date(s): June 5, 2020 (new) and July 5, 2020 (renewal, resubmission, revision); October 5, 2020 (new) and November 5, 2020 (renewal, resubmission, revision); June 5, 2021 (new) and July 5, 2021 (renewal, resubmission, revision); October 5, 2021 (new) and November 5, 2021 (renewal, resubmission, revision); June 5, 2022 (new) and July 5, 2022 (renewal, resubmission, revision); October 5, 2022 (new) and November 5, 2022 (renewal, resubmission, revision)
-
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
(PAR-20-139)National Institute of Allergy and Infectious DiseasesNational Institute on AgingApplication Receipt Date(s): May 13, 2020; September 13, 2020; January 13, 2021; May 13, 2021; September 13, 2021; January 13, 2022; May 13, 2022; September 13, 2022; January 13, 2023
-
Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional)
(RFA-AG-21-009)National Institute on AgingApplication Receipt Date(s): October 1, 2020. No late applications will be accepted for this funding opportunity announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed)
(RFA-AG-21-018)National Institute on AgingApplication Receipt Date(s): October 1, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
-
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed)
(RFA-AG-21-019)National Institute on AgingApplication Receipt Date(s): September 15, 2020 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date.
-
Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-20-015)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
(RFA-AI-20-028)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 29, 2020
-
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)
(RFA-AR-21-004)National Institute of Arthritis and Musculoskeletal and Skin DiseasesApplication Receipt Date(s): August 11, 2020, by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed)
(RFA-DE-20-006)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): July 8 20 , 2020 No late applications will be accepted for this Funding Opportunity Announcement
-
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed)
(RFA-DE-20-007)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): July 8, 2020; No late applications will be accepted for this Funding Opportunity Announcement
-
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
(RFA-DK-20-006)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): July 22, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
-
Retail Food Safety Association Collaboration (U18) Clinical Trial Not Allowed
(RFA-FD-20-028)Food and Drug AdministrationApplication Receipt Date(s): May 13, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
(RFA-FD-20-030)Food and Drug AdministrationApplication Receipt Date(s): May 11, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed
(RFA-FD-20-031)Food and Drug AdministrationApplication Receipt Date(s): May 18, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed)
(RFA-HD-21-010)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed)
(RFA-HD-21-014)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): May 27, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HG-20-019)National Human Genome Research InstituteApplication Receipt Date(s): June 24, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional)
(RFA-HL-21-007)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): June 8, 2020
-
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
(RFA-HL-21-008)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): June 8, 2020
-
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
(RFA-HL-21-009)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): June 8, 2020
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 8, 2024
For technical issues E-mail OER Webmaster